Tag Archives: Disease-Modifying Treatments for Dementia

Cognitive Symptoms of Alzheimer’s Disease: Management and Prevention? (BMJ)

Summary A review investigates pharmacological treatments for cognitive symptoms in Alzheimer’s Disease at different phases in progression of the disease, in the context of the paucity of effective disease-modifying interventions. Discrepancies between different national and international guidelines, regarding the prescription … Continue reading

Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Young Blood Infusion Recapitulates Folklore: Vampire Therapy for Dementia? (Telegraph / CTAD / JPAD)

Summary A small trial to check the safety and tolerability of youthful blood infusions for the treatment or amelioration of Alzheimer’s Disease has detected early signs of improvement in activities of daily living. Randomly selected individuals from just 18 over-65 … Continue reading

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Models of Dementia Care, Non-Pharmacological Treatments, Quick Insights, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

NICE Participation in European ROADMAP Project: Faster Access to Alzheimer’s Disease Drugs? (NICE)

Summary NICE is participating in the ROADMAP initiative, which is working on a sustainable platform for “real world” evidence generation concerning Alzheimer’s Disease and (hopefully) faster development of disease-modifying drugs. “The IMI (Innovative Medicines Initiative) is Europe’s largest public-private partnership, … Continue reading

Posted in Commissioning, For Researchers (mostly), In the News, International, National, Quick Insights, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment